{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33754"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33754","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Economic Evaluation of Tuberculosis Preventive Treatment","abstract":"At the United Nations General Assembly, Bangladesh committed to providing tuberculosis preventive treatment to approximately one million high-risk individuals, including close household contacts of tuberculosis patients, between 2023 and 2027. Since the commitment, the funding landscape in global health has changed amid global politics. Therefore, in a resource-constrained environment like Bangladesh, it is crucial to identify suitable implementation tools that are not resource-intensive and maximize input efficiency. This thesis looks at three areas related to TB infection: how well three different skin tests detect TB infection for their cost, which of two treatment options works better for treating TB infection, and whether people manage their treatment better on their own or with the help of a digital reminder tool. The results showed that a 3-month treatment taken once a week (isoniazid with rifapentine) works better and costs less than a 3-month treatment taken every day (isoniazid and rifampicin). Among the skin tests, the two newer options, Diaskintest and Cy-TB, were both better and cheaper than the older standard test (the Tuberculin skin test). The digital reminder tool costs more than letting people manage treatment on their own, but it also leads to better health outcomes: it costs about USD 830 to gain one extra year of healthy life when using the digital tool.","abstract_html":"At the United Nations General Assembly, Bangladesh committed to providing tuberculosis preventive treatment to approximately one million high-risk individuals, including close household contacts of tuberculosis patients, between 2023 and 2027. Since the commitment, the funding landscape in global health has changed amid global politics. Therefore, in a resource-constrained environment like Bangladesh, it is crucial to identify suitable implementation tools that are not resource-intensive and maximize input efficiency. This thesis looks at three areas related to TB infection: how well three different skin tests detect TB infection for their cost, which of two treatment options works better for treating TB infection, and whether people manage their treatment better on their own or with the help of a digital reminder tool. The results showed that a 3-month treatment taken once a week (isoniazid with rifapentine) works better and costs less than a 3-month treatment taken every day (isoniazid and rifampicin). Among the skin tests, the two newer options, Diaskintest and Cy-TB, were both better and cheaper than the older standard test (the Tuberculin skin test). The digital reminder tool costs more than letting people manage treatment on their own, but it also leads to better health outcomes: it costs about USD 830 to gain one extra year of healthy life when using the digital tool.","abstract_has_math":false,"creators":["Pushpita Samina"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Health Policy","school":null,"contributors":[],"advisors":["Guindon, Emmanuel","Tarride, Jean Eric","Hurley, Jeremiah","Zwerling, Alice"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:30:54Z","subjects":["Tuberculosis","Prevention","Economic evaluation","Global health"],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25524"],"render_values":[{"text":"https://doi.org/10.71548/25524","href":"https://doi.org/10.71548/25524","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33754","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33754","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33754","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Guindon, Emmanuel","Tarride, Jean Eric","Hurley, Jeremiah","Zwerling, Alice"]},{"key":"dc:contributor.department","label":"Department","values":["Health Policy"]},{"key":"dc:creator","label":"Author","values":["Pushpita Samina"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-12T23:28:55Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Dissertation","Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Tuberculosis","Prevention","Economic evaluation","Global health"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33754","https://doi.org/10.71548/25524"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["At the United Nations General Assembly, Bangladesh committed to providing tuberculosis preventive treatment to approximately one million high-risk individuals, including close household contacts of tuberculosis patients, between 2023 and 2027. Since the commitment, the funding landscape in global health has changed amid global politics. Therefore, in a resource-constrained environment like Bangladesh, it is crucial to identify suitable implementation tools that are not resource-intensive and maximize input efficiency. This thesis looks at three areas related to TB infection: how well three different skin tests detect TB infection for their cost, which of two treatment options works better for treating TB infection, and whether people manage their treatment better on their own or with the help of a digital reminder tool. The results showed that a 3-month treatment taken once a week (isoniazid with rifapentine) works better and costs less than a 3-month treatment taken every day (isoniazid and rifampicin). Among the skin tests, the two newer options, Diaskintest and Cy-TB, were both better and cheaper than the older standard test (the Tuberculin skin test). The digital reminder tool costs more than letting people manage treatment on their own, but it also leads to better health outcomes: it costs about USD 830 to gain one extra year of healthy life when using the digital tool."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:title","label":"Title","values":["Economic Evaluation of Tuberculosis Preventive Treatment"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Guindon, Emmanuel","Tarride, Jean Eric","Hurley, Jeremiah","Zwerling, Alice"],"dc:contributor.department":["Health Policy"],"dc:creator":["Pushpita Samina"],"dc:date.accessioned":["2026-10-12T23:28:55Z"],"dc:date.issued":["2026"],"dc:description.abstract":["At the United Nations General Assembly, Bangladesh committed to providing tuberculosis preventive treatment to approximately one million high-risk individuals, including close household contacts of tuberculosis patients, between 2023 and 2027. Since the commitment, the funding landscape in global health has changed amid global politics. Therefore, in a resource-constrained environment like Bangladesh, it is crucial to identify suitable implementation tools that are not resource-intensive and maximize input efficiency. This thesis looks at three areas related to TB infection: how well three different skin tests detect TB infection for their cost, which of two treatment options works better for treating TB infection, and whether people manage their treatment better on their own or with the help of a digital reminder tool. The results showed that a 3-month treatment taken once a week (isoniazid with rifapentine) works better and costs less than a 3-month treatment taken every day (isoniazid and rifampicin). Among the skin tests, the two newer options, Diaskintest and Cy-TB, were both better and cheaper than the older standard test (the Tuberculin skin test). The digital reminder tool costs more than letting people manage treatment on their own, but it also leads to better health outcomes: it costs about USD 830 to gain one extra year of healthy life when using the digital tool."],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33754","https://doi.org/10.71548/25524"],"dc:language.iso":["en"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"dc:subject":["Tuberculosis","Prevention","Economic evaluation","Global health"],"dc:title":["Economic Evaluation of Tuberculosis Preventive Treatment"],"dc:type":["Dissertation","Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:30:54Z"}